> top > projects > spacy-test > docs > PubMed:3922218 > annotations
TextAE configuration unavailable!
spacy-test Home  

PubMed:3922218 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-3 DT denotes The
spaCy_T1 4-8 NN denotes role
spaCy_T2 9-11 IN denotes of
spaCy_T3 12-26 NNS denotes prostaglandins
spaCy_T4 27-29 IN denotes in
spaCy_T5 30-35 JJ denotes human
spaCy_T6 36-48 NN denotes hypertension
spaCy_T7 48-49 . denotes .
spaCy_T8 50-51 DT denotes A
spaCy_T9 52-57 JJ denotes large
spaCy_T10 58-62 NN denotes body
spaCy_T11 63-65 IN denotes of
spaCy_T12 66-74 NN denotes evidence
spaCy_T13 75-83 VBZ denotes supports
spaCy_T14 84-87 DT denotes the
spaCy_T15 88-95 NN denotes concept
spaCy_T16 96-100 WDT denotes that
spaCy_T17 101-115 VBZ denotes prostaglandins
spaCy_T18 116-117 -LRB- denotes (
spaCy_T19 117-119 NNP denotes PG
spaCy_T20 119-120 -RRB- denotes )
spaCy_T21 121-124 VBP denotes are
spaCy_T22 125-136 RB denotes importantly
spaCy_T23 137-145 VBN denotes involved
spaCy_T24 146-148 IN denotes in
spaCy_T25 149-157 JJ denotes arterial
spaCy_T26 158-166 NN denotes pressure
spaCy_T27 167-177 NN denotes regulation
spaCy_T28 177-178 . denotes .
spaCy_T29 179-186 JJ denotes Various
spaCy_T30 187-190 NNS denotes PGs
spaCy_T31 190-191 , denotes ,
spaCy_T32 192-202 RB denotes especially
spaCy_T33 203-207 CD denotes PGE2
spaCy_T34 208-211 CC denotes and
spaCy_T35 212-224 NN denotes prostacyclin
spaCy_T36 225-226 -LRB- denotes (
spaCy_T37 226-230 NNP denotes PGI2
spaCy_T38 230-231 -RRB- denotes )
spaCy_T39 232-235 MD denotes may
spaCy_T40 236-245 VB denotes influence
spaCy_T41 246-251 NN denotes blood
spaCy_T42 252-260 NN denotes pressure
spaCy_T43 261-268 IN denotes through
spaCy_T44 269-276 NN denotes control
spaCy_T45 277-279 IN denotes of
spaCy_T46 280-288 JJ denotes vascular
spaCy_T47 289-293 NN denotes tone
spaCy_T48 293-294 , denotes ,
spaCy_T49 295-301 NN denotes sodium
spaCy_T50 302-311 NN denotes excretion
spaCy_T51 311-312 , denotes ,
spaCy_T52 313-316 CC denotes and
spaCy_T53 317-322 NN denotes renin
spaCy_T54 323-330 NN denotes release
spaCy_T55 330-331 . denotes .
spaCy_T56 332-342 NNP denotes Inhibition
spaCy_T57 343-345 IN denotes of
spaCy_T58 346-348 NNP denotes PG
spaCy_T59 349-358 NN denotes synthesis
spaCy_T60 359-361 IN denotes by
spaCy_T61 362-374 JJ denotes nonsteroidal
spaCy_T62 375-391 JJ denotes antiinflammatory
spaCy_T63 392-397 NNS denotes drugs
spaCy_T64 398-399 -LRB- denotes (
spaCy_T65 399-404 NNP denotes NSAID
spaCy_T66 404-405 -RRB- denotes )
spaCy_T67 406-414 VBZ denotes augments
spaCy_T68 415-418 DT denotes the
spaCy_T69 419-434 NN denotes vasoconstrictor
spaCy_T70 435-443 NN denotes response
spaCy_T71 444-446 TO denotes to
spaCy_T72 447-456 JJ denotes exogenous
spaCy_T73 457-465 NNS denotes pressors
spaCy_T74 466-470 JJ denotes such
spaCy_T75 471-473 IN denotes as
spaCy_T76 474-485 NN denotes angiotensin
spaCy_T77 486-488 NNP denotes II
spaCy_T78 488-489 , denotes ,
spaCy_T79 490-498 NN denotes arginine
spaCy_T80 499-510 NN denotes vasopressin
spaCy_T81 511-512 -LRB- denotes (
spaCy_T82 512-515 NNP denotes AVP
spaCy_T83 515-516 -RRB- denotes )
spaCy_T84 516-517 , denotes ,
spaCy_T85 518-521 CC denotes and
spaCy_T86 522-537 NN denotes fludrocortisone
spaCy_T87 537-538 . denotes .
spaCy_T88 539-542 DT denotes The
spaCy_T89 543-548 JJ denotes acute
spaCy_T90 549-563 NN denotes administration
spaCy_T91 564-566 IN denotes of
spaCy_T92 567-572 NNP denotes NSAID
spaCy_T93 573-575 TO denotes to
spaCy_T94 576-582 DT denotes either
spaCy_T95 583-595 JJ denotes normotensive
spaCy_T96 596-598 CC denotes or
spaCy_T97 599-608 JJ denotes untreated
spaCy_T98 609-621 JJ denotes hypertensive
spaCy_T99 622-630 NNS denotes subjects
spaCy_T100 631-638 NNS denotes results
spaCy_T101 639-641 IN denotes in
spaCy_T102 642-644 DT denotes an
spaCy_T103 645-653 NN denotes increase
spaCy_T104 654-656 IN denotes in
spaCy_T105 657-665 JJ denotes arterial
spaCy_T106 666-674 NN denotes pressure
spaCy_T107 675-678 CC denotes and
spaCy_T108 679-689 JJ denotes peripheral
spaCy_T109 690-700 NN denotes resistance
spaCy_T110 700-701 : denotes ;
spaCy_T111 702-711 JJ denotes long-term
spaCy_T112 712-726 NN denotes administration
spaCy_T113 726-727 , denotes ,
spaCy_T114 728-735 RB denotes however
spaCy_T115 735-736 , denotes ,
spaCy_T116 737-739 VBZ denotes is
spaCy_T117 740-750 VBN denotes associated
spaCy_T118 751-755 IN denotes with
spaCy_T119 756-762 JJ denotes little
spaCy_T120 763-765 CC denotes or
spaCy_T121 766-768 DT denotes no
spaCy_T122 769-775 NN denotes change
spaCy_T123 776-778 IN denotes in
spaCy_T124 779-784 NN denotes blood
spaCy_T125 785-793 NN denotes pressure
spaCy_T126 793-794 , denotes ,
spaCy_T127 795-803 RB denotes possibly
spaCy_T128 804-811 IN denotes because
spaCy_T129 812-814 IN denotes of
spaCy_T130 815-816 DT denotes a
spaCy_T131 817-826 NN denotes reduction
spaCy_T132 827-829 IN denotes in
spaCy_T133 830-837 JJ denotes cardiac
spaCy_T134 838-844 NN denotes output
spaCy_T135 844-845 . denotes .
spaCy_T136 846-854 IN denotes Although
spaCy_T137 855-860 NNP denotes NSAID
spaCy_T138 861-865 VBP denotes have
spaCy_T139 866-872 JJ denotes little
spaCy_T140 873-882 NN denotes influence
spaCy_T141 883-885 IN denotes on
spaCy_T142 886-891 NN denotes blood
spaCy_T143 892-900 NN denotes pressure
spaCy_T144 901-903 IN denotes in
spaCy_T145 904-916 JJ denotes normotensive
spaCy_T146 917-925 NNS denotes subjects
spaCy_T147 926-928 CC denotes or
spaCy_T148 929-938 JJ denotes untreated
spaCy_T149 939-952 NNS denotes hypertensives
spaCy_T150 952-953 , denotes ,
spaCy_T151 954-964 NN denotes inhibition
spaCy_T152 965-967 IN denotes of
spaCy_T153 968-970 NNP denotes PG
spaCy_T154 971-980 NN denotes synthesis
spaCy_T155 981-987 NNS denotes blunts
spaCy_T156 988-990 CC denotes or
spaCy_T157 991-1000 VBZ denotes abolishes
spaCy_T158 1001-1004 DT denotes the
spaCy_T159 1005-1021 JJ denotes antihypertensive
spaCy_T160 1022-1028 NN denotes effect
spaCy_T161 1029-1031 IN denotes of
spaCy_T162 1032-1036 JJS denotes most
spaCy_T163 1037-1053 JJ denotes antihypertensive
spaCy_T164 1054-1060 NNS denotes agents
spaCy_T165 1060-1061 . denotes .
spaCy_T166 1062-1067 NNP denotes NSAID
spaCy_T167 1068-1078 VB denotes antagonize
spaCy_T168 1079-1082 DT denotes the
spaCy_T169 1083-1096 NN denotes vasodepressor
spaCy_T170 1097-1103 NN denotes action
spaCy_T171 1104-1106 IN denotes of
spaCy_T172 1107-1116 NNS denotes diuretics
spaCy_T173 1116-1117 , denotes ,
spaCy_T174 1118-1137 JJ denotes beta-adrenoreceptor
spaCy_T175 1138-1149 NNS denotes antagonists
spaCy_T176 1149-1150 , denotes ,
spaCy_T177 1151-1163 NNS denotes vasodilators
spaCy_T178 1163-1164 , denotes ,
spaCy_T179 1165-1168 CC denotes and
spaCy_T180 1169-1179 VBG denotes converting
spaCy_T181 1180-1186 NN denotes enzyme
spaCy_T182 1187-1197 NNS denotes inhibitors
spaCy_T183 1197-1198 . denotes .
spaCy_T184 1199-1211 RB denotes Consequently
spaCy_T185 1211-1212 , denotes ,
spaCy_T186 1213-1219 JJ denotes potent
spaCy_T187 1220-1225 NNP denotes NSAID
spaCy_T188 1226-1232 MD denotes should
spaCy_T189 1233-1235 VB denotes be
spaCy_T190 1236-1240 VBN denotes used
spaCy_T191 1241-1245 IN denotes with
spaCy_T192 1246-1253 NN denotes caution
spaCy_T193 1253-1254 , denotes ,
spaCy_T194 1255-1257 IN denotes if
spaCy_T195 1258-1260 IN denotes at
spaCy_T196 1261-1264 DT denotes all
spaCy_T197 1264-1265 , denotes ,
spaCy_T198 1266-1272 IN denotes during
spaCy_T199 1273-1282 NN denotes treatment
spaCy_T200 1283-1285 IN denotes of
spaCy_T201 1286-1298 JJ denotes hypertensive
spaCy_T202 1299-1307 NNS denotes patients
spaCy_T203 1307-1308 . denotes .
spaCy_T204 1309-1317 JJ denotes Numerous
spaCy_T205 1318-1325 NNS denotes studies
spaCy_T206 1326-1330 VBP denotes have
spaCy_T207 1331-1339 VBN denotes examined
spaCy_T208 1340-1345 JJ denotes renal
spaCy_T209 1346-1348 NN denotes PG
spaCy_T210 1349-1359 NN denotes production
spaCy_T211 1360-1362 IN denotes in
spaCy_T212 1363-1372 JJ denotes essential
spaCy_T213 1373-1385 NN denotes hypertension
spaCy_T214 1386-1387 -LRB- denotes (
spaCy_T215 1387-1389 NNP denotes EH
spaCy_T216 1389-1390 -RRB- denotes )
spaCy_T217 1390-1391 . denotes .
spaCy_T218 1392-1395 DT denotes The
spaCy_T219 1396-1404 NN denotes majority
spaCy_T220 1405-1409 VBP denotes have
spaCy_T221 1410-1422 VBN denotes demonstrated
spaCy_T222 1423-1430 VBN denotes reduced
spaCy_T223 1431-1436 JJ denotes basal
spaCy_T224 1437-1440 CC denotes and
spaCy_T225 1441-1451 VBD denotes stimulated
spaCy_T226 1452-1459 JJ denotes urinary
spaCy_T227 1460-1464 NNP denotes PGE2
spaCy_T228 1465-1474 NN denotes excretion
spaCy_T229 1475-1477 IN denotes in
spaCy_T230 1478-1480 NNP denotes EH
spaCy_T231 1481-1489 VBN denotes compared
spaCy_T232 1490-1492 TO denotes to
spaCy_T233 1493-1505 JJ denotes normotensive
spaCy_T234 1506-1514 NNS denotes subjects
spaCy_T235 1514-1515 , denotes ,
spaCy_T236 1516-1519 CC denotes but
spaCy_T237 1520-1525 EX denotes there
spaCy_T238 1526-1528 VBZ denotes is
spaCy_T239 1529-1540 JJ denotes substantial
spaCy_T240 1541-1548 VBP denotes overlap
spaCy_T241 1548-1549 . denotes .
spaCy_T242 1550-1562 RB denotes Nevertheless
spaCy_T243 1562-1563 , denotes ,
spaCy_T244 1564-1569 JJ denotes renal
spaCy_T245 1570-1574 NNP denotes PGE2
spaCy_T246 1575-1584 NN denotes synthesis
spaCy_T247 1585-1587 VBZ denotes is
spaCy_T248 1588-1601 RB denotes significantly
spaCy_T249 1602-1611 VBN denotes decreased
spaCy_T250 1612-1614 IN denotes in
spaCy_T251 1615-1628 RB denotes approximately
spaCy_T252 1629-1638 NN denotes one-third
spaCy_T253 1639-1641 IN denotes of
spaCy_T254 1642-1650 NNS denotes patients
spaCy_T255 1651-1655 IN denotes with
spaCy_T256 1656-1658 NNP denotes EH
spaCy_T257 1658-1659 . denotes .
spaCy_T258 1660-1661 DT denotes A
spaCy_T259 1662-1668 JJ denotes recent
spaCy_T260 1669-1679 JJ denotes innovative
spaCy_T261 1680-1688 NN denotes approach
spaCy_T262 1689-1691 TO denotes to
spaCy_T263 1692-1700 JJ denotes arterial
spaCy_T264 1701-1709 NN denotes pressure
spaCy_T265 1710-1720 NN denotes regulation
spaCy_T266 1721-1724 VBZ denotes has
spaCy_T267 1725-1732 VBN denotes focused
spaCy_T268 1733-1735 IN denotes on
spaCy_T269 1736-1743 JJ denotes dietary
spaCy_T270 1744-1759 NN denotes supplementation
spaCy_T271 1760-1764 IN denotes with
spaCy_T272 1765-1780 JJ denotes polyunsaturated
spaCy_T273 1781-1786 JJ denotes fatty
spaCy_T274 1787-1792 NNS denotes acids
spaCy_T275 1793-1794 -LRB- denotes (
spaCy_T276 1794-1798 NNP denotes PUFA
spaCy_T277 1798-1799 -RRB- denotes )
spaCy_T278 1799-1800 , denotes ,
spaCy_T279 1801-1811 RB denotes especially
spaCy_T280 1812-1820 JJ denotes linoleic
spaCy_T281 1821-1825 NN denotes acid
spaCy_T282 1826-1829 CC denotes and
spaCy_T283 1830-1846 JJ denotes eicosapentaenoic
spaCy_T284 1847-1851 NN denotes acid
spaCy_T285 1851-1852 . denotes .
spaCy_T286 1853-1860 JJ denotes Several
spaCy_T287 1861-1867 NNS denotes groups
spaCy_T288 1868-1872 VBP denotes have
spaCy_T289 1873-1885 VBN denotes demonstrated
spaCy_T290 1886-1890 IN denotes that
spaCy_T291 1891-1900 JJ denotes long-term
spaCy_T292 1901-1908 JJ denotes dietary
spaCy_T293 1909-1924 NN denotes supplementation
spaCy_T294 1925-1929 IN denotes with
spaCy_T295 1930-1934 NNP denotes PUFA
spaCy_T296 1935-1942 VBZ denotes reduces
spaCy_T297 1943-1948 NN denotes blood
spaCy_T298 1949-1957 NN denotes pressure
spaCy_T299 1958-1960 IN denotes in
spaCy_T300 1961-1965 DT denotes both
spaCy_T301 1966-1978 JJ denotes normotensive
spaCy_T302 1979-1990 NNS denotes individuals
spaCy_T303 1991-1994 CC denotes and
spaCy_T304 1995-1997 IN denotes in
spaCy_T305 1998-2006 NNS denotes patients
spaCy_T306 2007-2011 IN denotes with
spaCy_T307 2012-2014 NNP denotes EH
spaCy_T308 2014-2015 . denotes .
spaCy_T309 2015-2016 -LRB- denotes (
spaCy_T310 2016-2024 NNP denotes ABSTRACT
spaCy_T311 2025-2034 NNP denotes TRUNCATED
spaCy_T312 2035-2037 NNP denotes AT
spaCy_T313 2038-2041 CD denotes 250
spaCy_T314 2042-2047 NNS denotes WORDS
spaCy_T315 2047-2048 -RRB- denotes )
spaCy_R0 spaCy_T0 spaCy_T1 det The,role
spaCy_R1 spaCy_T1 spaCy_T1 ROOT role,role
spaCy_R10 spaCy_T10 spaCy_T13 nsubj body,supports
spaCy_R100 spaCy_T100 spaCy_T100 ROOT results,results
spaCy_R101 spaCy_T101 spaCy_T100 prep in,results
spaCy_R102 spaCy_T102 spaCy_T103 det an,increase
spaCy_R103 spaCy_T103 spaCy_T101 pobj increase,in
spaCy_R104 spaCy_T104 spaCy_T103 prep in,increase
spaCy_R105 spaCy_T105 spaCy_T106 amod arterial,pressure
spaCy_R106 spaCy_T106 spaCy_T104 pobj pressure,in
spaCy_R107 spaCy_T107 spaCy_T106 cc and,pressure
spaCy_R108 spaCy_T108 spaCy_T109 amod peripheral,resistance
spaCy_R109 spaCy_T109 spaCy_T106 conj resistance,pressure
spaCy_R11 spaCy_T11 spaCy_T10 prep of,body
spaCy_R110 spaCy_T110 spaCy_T100 punct ;,results
spaCy_R111 spaCy_T111 spaCy_T112 amod long-term,administration
spaCy_R112 spaCy_T112 spaCy_T100 conj administration,results
spaCy_R113 spaCy_T113 spaCy_T117 punct ",",associated
spaCy_R114 spaCy_T114 spaCy_T117 advmod however,associated
spaCy_R115 spaCy_T115 spaCy_T117 punct ",",associated
spaCy_R116 spaCy_T116 spaCy_T117 auxpass is,associated
spaCy_R117 spaCy_T117 spaCy_T100 acl associated,results
spaCy_R118 spaCy_T118 spaCy_T117 prep with,associated
spaCy_R119 spaCy_T119 spaCy_T122 amod little,change
spaCy_R12 spaCy_T12 spaCy_T11 pobj evidence,of
spaCy_R120 spaCy_T120 spaCy_T119 cc or,little
spaCy_R121 spaCy_T121 spaCy_T119 conj no,little
spaCy_R122 spaCy_T122 spaCy_T118 pobj change,with
spaCy_R123 spaCy_T123 spaCy_T122 prep in,change
spaCy_R124 spaCy_T124 spaCy_T125 compound blood,pressure
spaCy_R125 spaCy_T125 spaCy_T123 pobj pressure,in
spaCy_R126 spaCy_T126 spaCy_T117 punct ",",associated
spaCy_R127 spaCy_T127 spaCy_T128 advmod possibly,because
spaCy_R128 spaCy_T128 spaCy_T117 prep because,associated
spaCy_R129 spaCy_T129 spaCy_T128 pcomp of,because
spaCy_R13 spaCy_T13 spaCy_T13 ROOT supports,supports
spaCy_R130 spaCy_T130 spaCy_T131 det a,reduction
spaCy_R131 spaCy_T131 spaCy_T128 pobj reduction,because
spaCy_R132 spaCy_T132 spaCy_T131 prep in,reduction
spaCy_R133 spaCy_T133 spaCy_T134 amod cardiac,output
spaCy_R134 spaCy_T134 spaCy_T132 pobj output,in
spaCy_R135 spaCy_T135 spaCy_T117 punct .,associated
spaCy_R136 spaCy_T136 spaCy_T138 mark Although,have
spaCy_R137 spaCy_T137 spaCy_T138 nsubj NSAID,have
spaCy_R138 spaCy_T138 spaCy_T138 ROOT have,have
spaCy_R139 spaCy_T139 spaCy_T140 amod little,influence
spaCy_R14 spaCy_T14 spaCy_T15 det the,concept
spaCy_R140 spaCy_T140 spaCy_T138 dobj influence,have
spaCy_R141 spaCy_T141 spaCy_T140 prep on,influence
spaCy_R142 spaCy_T142 spaCy_T143 compound blood,pressure
spaCy_R143 spaCy_T143 spaCy_T141 pobj pressure,on
spaCy_R144 spaCy_T144 spaCy_T143 prep in,pressure
spaCy_R145 spaCy_T145 spaCy_T146 amod normotensive,subjects
spaCy_R146 spaCy_T146 spaCy_T144 pobj subjects,in
spaCy_R147 spaCy_T147 spaCy_T146 cc or,subjects
spaCy_R148 spaCy_T148 spaCy_T149 amod untreated,hypertensives
spaCy_R149 spaCy_T149 spaCy_T146 conj hypertensives,subjects
spaCy_R15 spaCy_T15 spaCy_T13 dobj concept,supports
spaCy_R150 spaCy_T150 spaCy_T149 punct ",",hypertensives
spaCy_R151 spaCy_T151 spaCy_T140 conj inhibition,influence
spaCy_R152 spaCy_T152 spaCy_T140 prep of,influence
spaCy_R153 spaCy_T153 spaCy_T154 compound PG,synthesis
spaCy_R154 spaCy_T154 spaCy_T155 compound synthesis,blunts
spaCy_R155 spaCy_T155 spaCy_T152 pobj blunts,of
spaCy_R156 spaCy_T156 spaCy_T155 cc or,blunts
spaCy_R157 spaCy_T157 spaCy_T138 prep abolishes,have
spaCy_R158 spaCy_T158 spaCy_T160 det the,effect
spaCy_R159 spaCy_T159 spaCy_T160 amod antihypertensive,effect
spaCy_R16 spaCy_T16 spaCy_T17 nsubj that,prostaglandins
spaCy_R160 spaCy_T160 spaCy_T157 dobj effect,abolishes
spaCy_R161 spaCy_T161 spaCy_T160 prep of,effect
spaCy_R162 spaCy_T162 spaCy_T164 amod most,agents
spaCy_R163 spaCy_T163 spaCy_T164 amod antihypertensive,agents
spaCy_R164 spaCy_T164 spaCy_T161 pobj agents,of
spaCy_R165 spaCy_T165 spaCy_T138 punct .,have
spaCy_R166 spaCy_T166 spaCy_T167 nsubj NSAID,antagonize
spaCy_R167 spaCy_T167 spaCy_T167 ROOT antagonize,antagonize
spaCy_R168 spaCy_T168 spaCy_T170 det the,action
spaCy_R169 spaCy_T169 spaCy_T170 compound vasodepressor,action
spaCy_R17 spaCy_T17 spaCy_T15 relcl prostaglandins,concept
spaCy_R170 spaCy_T170 spaCy_T167 dobj action,antagonize
spaCy_R171 spaCy_T171 spaCy_T170 prep of,action
spaCy_R172 spaCy_T172 spaCy_T171 pobj diuretics,of
spaCy_R173 spaCy_T173 spaCy_T175 punct ",",antagonists
spaCy_R174 spaCy_T174 spaCy_T175 amod beta-adrenoreceptor,antagonists
spaCy_R175 spaCy_T175 spaCy_T170 conj antagonists,action
spaCy_R176 spaCy_T176 spaCy_T175 punct ",",antagonists
spaCy_R177 spaCy_T177 spaCy_T175 conj vasodilators,antagonists
spaCy_R178 spaCy_T178 spaCy_T177 punct ",",vasodilators
spaCy_R179 spaCy_T179 spaCy_T177 cc and,vasodilators
spaCy_R18 spaCy_T18 spaCy_T19 punct (,PG
spaCy_R180 spaCy_T180 spaCy_T177 conj converting,vasodilators
spaCy_R181 spaCy_T181 spaCy_T182 compound enzyme,inhibitors
spaCy_R182 spaCy_T182 spaCy_T180 dobj inhibitors,converting
spaCy_R183 spaCy_T183 spaCy_T167 punct .,antagonize
spaCy_R184 spaCy_T184 spaCy_T190 advmod Consequently,used
spaCy_R185 spaCy_T185 spaCy_T190 punct ",",used
spaCy_R186 spaCy_T186 spaCy_T187 amod potent,NSAID
spaCy_R187 spaCy_T187 spaCy_T190 nsubjpass NSAID,used
spaCy_R188 spaCy_T188 spaCy_T190 aux should,used
spaCy_R189 spaCy_T189 spaCy_T190 auxpass be,used
spaCy_R19 spaCy_T19 spaCy_T17 appos PG,prostaglandins
spaCy_R190 spaCy_T190 spaCy_T190 ROOT used,used
spaCy_R191 spaCy_T191 spaCy_T190 prep with,used
spaCy_R192 spaCy_T192 spaCy_T191 pobj caution,with
spaCy_R193 spaCy_T193 spaCy_T190 punct ",",used
spaCy_R194 spaCy_T194 spaCy_T203 mark if,.
spaCy_R195 spaCy_T195 spaCy_T196 advmod at,all
spaCy_R196 spaCy_T196 spaCy_T194 advmod all,if
spaCy_R197 spaCy_T197 spaCy_T196 punct ",",all
spaCy_R198 spaCy_T198 spaCy_T196 prep during,all
spaCy_R199 spaCy_T199 spaCy_T198 pobj treatment,during
spaCy_R2 spaCy_T2 spaCy_T1 prep of,role
spaCy_R20 spaCy_T20 spaCy_T13 punct ),supports
spaCy_R200 spaCy_T200 spaCy_T199 prep of,treatment
spaCy_R201 spaCy_T201 spaCy_T202 amod hypertensive,patients
spaCy_R202 spaCy_T202 spaCy_T200 pobj patients,of
spaCy_R203 spaCy_T203 spaCy_T190 punct .,used
spaCy_R204 spaCy_T204 spaCy_T205 amod Numerous,studies
spaCy_R205 spaCy_T205 spaCy_T207 nsubj studies,examined
spaCy_R206 spaCy_T206 spaCy_T207 aux have,examined
spaCy_R207 spaCy_T207 spaCy_T207 ROOT examined,examined
spaCy_R208 spaCy_T208 spaCy_T210 amod renal,production
spaCy_R209 spaCy_T209 spaCy_T210 compound PG,production
spaCy_R21 spaCy_T21 spaCy_T21 ROOT are,are
spaCy_R210 spaCy_T210 spaCy_T207 dobj production,examined
spaCy_R211 spaCy_T211 spaCy_T210 prep in,production
spaCy_R212 spaCy_T212 spaCy_T213 amod essential,hypertension
spaCy_R213 spaCy_T213 spaCy_T211 pobj hypertension,in
spaCy_R214 spaCy_T214 spaCy_T215 punct (,EH
spaCy_R215 spaCy_T215 spaCy_T213 appos EH,hypertension
spaCy_R216 spaCy_T216 spaCy_T207 punct ),examined
spaCy_R217 spaCy_T217 spaCy_T207 punct .,examined
spaCy_R218 spaCy_T218 spaCy_T219 det The,majority
spaCy_R219 spaCy_T219 spaCy_T221 nsubj majority,demonstrated
spaCy_R22 spaCy_T22 spaCy_T23 advmod importantly,involved
spaCy_R220 spaCy_T220 spaCy_T221 aux have,demonstrated
spaCy_R221 spaCy_T221 spaCy_T221 ROOT demonstrated,demonstrated
spaCy_R222 spaCy_T222 spaCy_T223 amod reduced,basal
spaCy_R223 spaCy_T223 spaCy_T221 dobj basal,demonstrated
spaCy_R224 spaCy_T224 spaCy_T223 cc and,basal
spaCy_R225 spaCy_T225 spaCy_T223 conj stimulated,basal
spaCy_R226 spaCy_T226 spaCy_T228 amod urinary,excretion
spaCy_R227 spaCy_T227 spaCy_T228 compound PGE2,excretion
spaCy_R228 spaCy_T228 spaCy_T225 dobj excretion,stimulated
spaCy_R229 spaCy_T229 spaCy_T225 prep in,stimulated
spaCy_R23 spaCy_T23 spaCy_T21 acomp involved,are
spaCy_R230 spaCy_T230 spaCy_T229 pobj EH,in
spaCy_R231 spaCy_T231 spaCy_T221 prep compared,demonstrated
spaCy_R232 spaCy_T232 spaCy_T231 prep to,compared
spaCy_R233 spaCy_T233 spaCy_T234 amod normotensive,subjects
spaCy_R234 spaCy_T234 spaCy_T232 pobj subjects,to
spaCy_R235 spaCy_T235 spaCy_T221 punct ",",demonstrated
spaCy_R236 spaCy_T236 spaCy_T221 cc but,demonstrated
spaCy_R237 spaCy_T237 spaCy_T238 expl there,is
spaCy_R238 spaCy_T238 spaCy_T221 conj is,demonstrated
spaCy_R239 spaCy_T239 spaCy_T240 amod substantial,overlap
spaCy_R24 spaCy_T24 spaCy_T23 prep in,involved
spaCy_R240 spaCy_T240 spaCy_T238 attr overlap,is
spaCy_R241 spaCy_T241 spaCy_T238 punct .,is
spaCy_R242 spaCy_T242 spaCy_T249 advmod Nevertheless,decreased
spaCy_R243 spaCy_T243 spaCy_T249 punct ",",decreased
spaCy_R244 spaCy_T244 spaCy_T246 amod renal,synthesis
spaCy_R245 spaCy_T245 spaCy_T246 compound PGE2,synthesis
spaCy_R246 spaCy_T246 spaCy_T249 nsubjpass synthesis,decreased
spaCy_R247 spaCy_T247 spaCy_T249 auxpass is,decreased
spaCy_R248 spaCy_T248 spaCy_T249 advmod significantly,decreased
spaCy_R249 spaCy_T249 spaCy_T249 ROOT decreased,decreased
spaCy_R25 spaCy_T25 spaCy_T27 amod arterial,regulation
spaCy_R250 spaCy_T250 spaCy_T249 prep in,decreased
spaCy_R251 spaCy_T251 spaCy_T252 advmod approximately,one-third
spaCy_R252 spaCy_T252 spaCy_T250 pobj one-third,in
spaCy_R253 spaCy_T253 spaCy_T252 prep of,one-third
spaCy_R254 spaCy_T254 spaCy_T253 pobj patients,of
spaCy_R255 spaCy_T255 spaCy_T252 prep with,one-third
spaCy_R256 spaCy_T256 spaCy_T255 pobj EH,with
spaCy_R257 spaCy_T257 spaCy_T249 punct .,decreased
spaCy_R258 spaCy_T258 spaCy_T261 det A,approach
spaCy_R259 spaCy_T259 spaCy_T261 amod recent,approach
spaCy_R26 spaCy_T26 spaCy_T27 compound pressure,regulation
spaCy_R260 spaCy_T260 spaCy_T261 amod innovative,approach
spaCy_R261 spaCy_T261 spaCy_T267 nsubj approach,focused
spaCy_R262 spaCy_T262 spaCy_T261 prep to,approach
spaCy_R263 spaCy_T263 spaCy_T265 amod arterial,regulation
spaCy_R264 spaCy_T264 spaCy_T265 compound pressure,regulation
spaCy_R265 spaCy_T265 spaCy_T262 pobj regulation,to
spaCy_R266 spaCy_T266 spaCy_T267 aux has,focused
spaCy_R267 spaCy_T267 spaCy_T267 ROOT focused,focused
spaCy_R268 spaCy_T268 spaCy_T267 prep on,focused
spaCy_R269 spaCy_T269 spaCy_T270 amod dietary,supplementation
spaCy_R27 spaCy_T27 spaCy_T24 pobj regulation,in
spaCy_R270 spaCy_T270 spaCy_T268 pobj supplementation,on
spaCy_R271 spaCy_T271 spaCy_T270 prep with,supplementation
spaCy_R272 spaCy_T272 spaCy_T274 amod polyunsaturated,acids
spaCy_R273 spaCy_T273 spaCy_T274 amod fatty,acids
spaCy_R274 spaCy_T274 spaCy_T271 pobj acids,with
spaCy_R275 spaCy_T275 spaCy_T276 punct (,PUFA
spaCy_R276 spaCy_T276 spaCy_T274 appos PUFA,acids
spaCy_R277 spaCy_T277 spaCy_T276 punct ),PUFA
spaCy_R278 spaCy_T278 spaCy_T274 punct ",",acids
spaCy_R279 spaCy_T279 spaCy_T281 advmod especially,acid
spaCy_R28 spaCy_T28 spaCy_T21 punct .,are
spaCy_R280 spaCy_T280 spaCy_T281 amod linoleic,acid
spaCy_R281 spaCy_T281 spaCy_T274 conj acid,acids
spaCy_R282 spaCy_T282 spaCy_T281 cc and,acid
spaCy_R283 spaCy_T283 spaCy_T284 amod eicosapentaenoic,acid
spaCy_R284 spaCy_T284 spaCy_T281 conj acid,acid
spaCy_R285 spaCy_T285 spaCy_T267 punct .,focused
spaCy_R286 spaCy_T286 spaCy_T287 amod Several,groups
spaCy_R287 spaCy_T287 spaCy_T289 nsubj groups,demonstrated
spaCy_R288 spaCy_T288 spaCy_T289 aux have,demonstrated
spaCy_R289 spaCy_T289 spaCy_T289 ROOT demonstrated,demonstrated
spaCy_R29 spaCy_T29 spaCy_T30 amod Various,PGs
spaCy_R290 spaCy_T290 spaCy_T296 mark that,reduces
spaCy_R291 spaCy_T291 spaCy_T293 amod long-term,supplementation
spaCy_R292 spaCy_T292 spaCy_T293 amod dietary,supplementation
spaCy_R293 spaCy_T293 spaCy_T296 nsubj supplementation,reduces
spaCy_R294 spaCy_T294 spaCy_T293 prep with,supplementation
spaCy_R295 spaCy_T295 spaCy_T294 pobj PUFA,with
spaCy_R296 spaCy_T296 spaCy_T289 ccomp reduces,demonstrated
spaCy_R297 spaCy_T297 spaCy_T298 compound blood,pressure
spaCy_R298 spaCy_T298 spaCy_T296 dobj pressure,reduces
spaCy_R299 spaCy_T299 spaCy_T298 prep in,pressure
spaCy_R3 spaCy_T3 spaCy_T2 pobj prostaglandins,of
spaCy_R30 spaCy_T30 spaCy_T40 nsubj PGs,influence
spaCy_R300 spaCy_T300 spaCy_T302 det both,individuals
spaCy_R301 spaCy_T301 spaCy_T302 amod normotensive,individuals
spaCy_R302 spaCy_T302 spaCy_T299 pobj individuals,in
spaCy_R303 spaCy_T303 spaCy_T299 cc and,in
spaCy_R304 spaCy_T304 spaCy_T299 conj in,in
spaCy_R305 spaCy_T305 spaCy_T304 pobj patients,in
spaCy_R306 spaCy_T306 spaCy_T305 prep with,patients
spaCy_R307 spaCy_T307 spaCy_T306 pobj EH,with
spaCy_R308 spaCy_T308 spaCy_T289 punct .,demonstrated
spaCy_R309 spaCy_T309 spaCy_T310 punct (,ABSTRACT
spaCy_R31 spaCy_T31 spaCy_T30 punct ",",PGs
spaCy_R310 spaCy_T310 spaCy_T310 ROOT ABSTRACT,ABSTRACT
spaCy_R311 spaCy_T311 spaCy_T312 nsubj TRUNCATED,AT
spaCy_R312 spaCy_T312 spaCy_T310 appos AT,ABSTRACT
spaCy_R313 spaCy_T313 spaCy_T314 nummod 250,WORDS
spaCy_R314 spaCy_T314 spaCy_T310 appos WORDS,ABSTRACT
spaCy_R315 spaCy_T315 spaCy_T310 punct ),ABSTRACT
spaCy_R32 spaCy_T32 spaCy_T33 advmod especially,PGE2
spaCy_R33 spaCy_T33 spaCy_T35 nummod PGE2,prostacyclin
spaCy_R34 spaCy_T34 spaCy_T33 cc and,PGE2
spaCy_R35 spaCy_T35 spaCy_T30 appos prostacyclin,PGs
spaCy_R36 spaCy_T36 spaCy_T37 punct (,PGI2
spaCy_R37 spaCy_T37 spaCy_T35 appos PGI2,prostacyclin
spaCy_R38 spaCy_T38 spaCy_T30 punct ),PGs
spaCy_R39 spaCy_T39 spaCy_T40 aux may,influence
spaCy_R4 spaCy_T4 spaCy_T1 prep in,role
spaCy_R40 spaCy_T40 spaCy_T40 ROOT influence,influence
spaCy_R41 spaCy_T41 spaCy_T42 compound blood,pressure
spaCy_R42 spaCy_T42 spaCy_T40 dobj pressure,influence
spaCy_R43 spaCy_T43 spaCy_T40 prep through,influence
spaCy_R44 spaCy_T44 spaCy_T43 pobj control,through
spaCy_R45 spaCy_T45 spaCy_T44 prep of,control
spaCy_R46 spaCy_T46 spaCy_T47 amod vascular,tone
spaCy_R47 spaCy_T47 spaCy_T45 pobj tone,of
spaCy_R48 spaCy_T48 spaCy_T47 punct ",",tone
spaCy_R49 spaCy_T49 spaCy_T50 compound sodium,excretion
spaCy_R5 spaCy_T5 spaCy_T6 amod human,hypertension
spaCy_R50 spaCy_T50 spaCy_T47 conj excretion,tone
spaCy_R51 spaCy_T51 spaCy_T50 punct ",",excretion
spaCy_R52 spaCy_T52 spaCy_T50 cc and,excretion
spaCy_R53 spaCy_T53 spaCy_T54 compound renin,release
spaCy_R54 spaCy_T54 spaCy_T50 conj release,excretion
spaCy_R55 spaCy_T55 spaCy_T40 punct .,influence
spaCy_R56 spaCy_T56 spaCy_T67 nsubj Inhibition,augments
spaCy_R57 spaCy_T57 spaCy_T56 prep of,Inhibition
spaCy_R58 spaCy_T58 spaCy_T57 pobj PG,of
spaCy_R59 spaCy_T59 spaCy_T56 conj synthesis,Inhibition
spaCy_R6 spaCy_T6 spaCy_T4 pobj hypertension,in
spaCy_R60 spaCy_T60 spaCy_T56 prep by,Inhibition
spaCy_R61 spaCy_T61 spaCy_T63 nmod nonsteroidal,drugs
spaCy_R62 spaCy_T62 spaCy_T63 amod antiinflammatory,drugs
spaCy_R63 spaCy_T63 spaCy_T60 pobj drugs,by
spaCy_R64 spaCy_T64 spaCy_T65 punct (,NSAID
spaCy_R65 spaCy_T65 spaCy_T63 appos NSAID,drugs
spaCy_R66 spaCy_T66 spaCy_T63 punct ),drugs
spaCy_R67 spaCy_T67 spaCy_T67 ROOT augments,augments
spaCy_R68 spaCy_T68 spaCy_T70 det the,response
spaCy_R69 spaCy_T69 spaCy_T70 amod vasoconstrictor,response
spaCy_R7 spaCy_T7 spaCy_T1 punct .,role
spaCy_R70 spaCy_T70 spaCy_T67 dobj response,augments
spaCy_R71 spaCy_T71 spaCy_T70 prep to,response
spaCy_R72 spaCy_T72 spaCy_T73 amod exogenous,pressors
spaCy_R73 spaCy_T73 spaCy_T71 pobj pressors,to
spaCy_R74 spaCy_T74 spaCy_T75 amod such,as
spaCy_R75 spaCy_T75 spaCy_T73 prep as,pressors
spaCy_R76 spaCy_T76 spaCy_T77 compound angiotensin,II
spaCy_R77 spaCy_T77 spaCy_T75 pobj II,as
spaCy_R78 spaCy_T78 spaCy_T77 punct ",",II
spaCy_R79 spaCy_T79 spaCy_T80 compound arginine,vasopressin
spaCy_R8 spaCy_T8 spaCy_T10 det A,body
spaCy_R80 spaCy_T80 spaCy_T77 appos vasopressin,II
spaCy_R81 spaCy_T81 spaCy_T82 punct (,AVP
spaCy_R82 spaCy_T82 spaCy_T80 appos AVP,vasopressin
spaCy_R83 spaCy_T83 spaCy_T82 punct ),AVP
spaCy_R84 spaCy_T84 spaCy_T80 punct ",",vasopressin
spaCy_R85 spaCy_T85 spaCy_T80 cc and,vasopressin
spaCy_R86 spaCy_T86 spaCy_T80 conj fludrocortisone,vasopressin
spaCy_R87 spaCy_T87 spaCy_T67 punct .,augments
spaCy_R88 spaCy_T88 spaCy_T90 det The,administration
spaCy_R89 spaCy_T89 spaCy_T90 amod acute,administration
spaCy_R9 spaCy_T9 spaCy_T10 amod large,body
spaCy_R90 spaCy_T90 spaCy_T100 nsubj administration,results
spaCy_R91 spaCy_T91 spaCy_T90 prep of,administration
spaCy_R92 spaCy_T92 spaCy_T91 pobj NSAID,of
spaCy_R93 spaCy_T93 spaCy_T90 prep to,administration
spaCy_R94 spaCy_T94 spaCy_T95 preconj either,normotensive
spaCy_R95 spaCy_T95 spaCy_T93 pobj normotensive,to
spaCy_R96 spaCy_T96 spaCy_T95 cc or,normotensive
spaCy_R97 spaCy_T97 spaCy_T100 amod untreated,results
spaCy_R98 spaCy_T98 spaCy_T100 amod hypertensive,results
spaCy_R99 spaCy_T99 spaCy_T100 compound subjects,results